Tymlos
Chemical Name | abaloparatide |
Dosage Form | Injection (subcutaneous; 3120 mcg/1.56 mL) |
Drug Class | Hormones |
System | Musculoskeletal |
Company | Radius Health Inc |
Approval Year | 2017 |
Indication
- To treat osteoporosis in postmenopausal women at high risk of fracture.